Berlin-based Aignostics Secures €31.4 Million Series B Funding

In a significant stride for precision medicine, Aignostics, a pioneering artificial intelligence company, has announced the successful closure of a €31.4 million Series B funding round. This substantial investment underscores the growing reliance on AI to revolutionize the field of computational pathology.

The funding round, oversubscribed and led by ATHOS, also saw participation from prominent entities such as Mayo Clinic and HTGF, alongside existing investors like Wellington Partners and Boehringer Ingelheim Venture Fund. This brings Aignostics’ total funding to over $55 million, a testament to the confidence investors have in its cutting-edge AI models and strategic vision.

“At its core, Aignostics is a world-class machine learning company,” stated Julian Zachmann from ATHOS. “The field is advancing so quickly that, in order to succeed, AI companies need to avoid flashy distractions, stay laser-focused on the highest-quality science, and relentlessly innovate. Aignostics is doing just that.”

Strategic Partnerships and Innovations

Aignostics’ collaborations with esteemed institutions like Mayo Clinic are pivotal in developing foundational models for pathology. Jim Rogers, CEO of Mayo Clinic Digital Pathology, emphasized the potential impact of digital pathology paired with AI on patient diagnosis and treatment.

The new funding will bolster Aignostics’ offerings in target identification, translational research, and companion diagnostics (CDx). Viktor Matyas, CEO and Co-Founder of Aignostics, highlighted the launch of their first foundation model, RudolfV, as a key development. “With RudolfV, we’ve gained the ability to quickly develop cost-efficient algorithms that generalize to the real world,” he noted.

Future Prospects and Market Impact

As the landscape of precision medicine becomes increasingly complex, Aignostics is poised to lead the charge in integrating AI into biopharmaceutical research and diagnostics. The company’s strategic initiatives, including a major collaboration with Bayer, are set to propel its growth trajectory, particularly within the United States.

Niels Sharman, Senior Investment Manager at HTGF, expressed enthusiasm for Aignostics’ progress, stating, “We have been thoroughly impressed by Aignostics’ progress and their cutting-edge AI platform, which we believe will have a transformative impact on Pharma R&D.”

For more insights into Aignostics’ journey and strategic collaborations, refer to the original article on EU-Startups.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Mark Tampa Breaks Ground on 800‑Bed Luxury Student Housing Near USF

Landmark Properties has officially begun construction on The Mark Tampa, a six‑story luxury student community featuring over 800 beds, rooftop amenities, study spaces, retail, and modern unit layouts. Set to open before the 2027–2028 school year, the project signals strong investor confidence in North Tampa’s booming student housing market.

Florida’s Insurance Costs Erupt Into a 2026 Election Flashpoint

Florida’s property and auto insurance crisis is intensifying, setting the stage for a major political showdown ahead of the 2026 elections. Republicans argue recent reforms are finally stabilizing the market, while Democrats insist families are being crushed by soaring premiums and can’t wait for relief. With homeowners, condo associations, and insurers all feeling the pressure, lawmakers are preparing for one of the most consequential legislative battles in years.

A December Fed Cut Could Be Coming — But Don’t Expect Mortgage Rates to Drop

Markets are betting heavily on a Federal Reserve rate cut in December, but that doesn’t guarantee lower mortgage rates. Even with an 85% chance of a cut priced in, mortgage rates move more with the 10‑year Treasury than the Fed itself — and recent history shows rates can rise even when the Fed eases. Today’s 6.43% average rate is the lowest in over a year, but still unpredictable, making financial readiness more important than trying to time the market.

Grand Junction’s Commercial Real Estate Market Surges 36% as New Chains Fuel Regional Growth

Grand Junction is experiencing a powerful commercial real estate upswing, with 151 commercial units closed so far in 2025—a 36% jump from last year. Building permits are also up 23%, signaling expanding development momentum. Brokers say interest from national chains is accelerating the city’s evolution, bringing jobs, investment, and long‑term economic potential to Colorado’s Western Slope.

Nashville Ranks #6 in Emerging Trends in Real Estate 2026 Report

Nashville continues its rise as one of the nation’s most attractive real estate markets, landing the #6 spot in the Emerging Trends in Real Estate 2026 report from PwC and ULI. With strong demographic momentum, business expansion, and a development pipeline drawing national eyes, the city stands out amid shifting economic conditions. The report highlights fast‑growing sectors such as data centers, senior housing, and evolving office dynamics—offering real estate professionals valuable insight into where opportunities are emerging next.

CRE This Week: The Key Trends Reshaping Canada’s Commercial Real Estate Market in 2025

Canada’s commercial real estate sector continues to evolve rapidly, with new data revealing major transactions, shifting investment patterns, and emerging economic signals across the country. From resilient retail spending to cooling construction and regional standouts like Montreal and the Prairies, this week’s CRE pulse—powered by Altus Group’s research team—gives real estate, mortgage, and finance professionals a sharp snapshot of the market forces to watch as 2025 winds down.